Medacta Group is a Switzerland‐based medical device company specializing in the design, manufacture and marketing of orthopedic and spine surgery solutions. The company develops a range of implants, instruments and surgical protocols aimed at improving patient outcomes in hip, knee, shoulder, spine and sports medicine procedures. Its product portfolio includes both standard and patient‐specific systems, supported by minimally invasive techniques and proprietary surgical instrumentation.
Central to Medacta’s offering are its joint replacement systems, which cover total and partial hip and knee arthroplasty. The company places particular emphasis on patient‐matched solutions, providing preoperative planning and customized instrumentation that align with each patient’s unique anatomy. In the spinal surgery segment, Medacta offers interbody fusion devices, pedicle screw systems and surgical navigation tools designed to facilitate reproducible, less invasive procedures.
With a presence in Europe, North and South America, Asia Pacific and the Middle East, Medacta distributes its products through a network of wholly owned subsidiaries and partner distributors in more than 50 countries. The company also operates specialized training centers and collaborates with leading orthopedic surgeons and academic institutions to advance surgical education and clinical research, reinforcing its focus on continuous innovation and best‐practice protocols.
Founded in 1999 by Dr. Massimo Calandriello, who serves as chairman and CEO, Medacta has maintained a founder‐led governance structure that underscores its commitment to R&D and surgeon‐led design. Over the years, the company has expanded its footprint through strategic partnerships and product launches, cementing its reputation as a developer of precision orthopedic and spine technologies.
AI Generated. May Contain Errors.
Free MEDGF Stock Alerts